Brief: PLX Pharma Reports Q1 Loss Per Share Of $2.71
10/05/2019 13:42
May 10 (Reuters) - PLx Pharma Inc PLXP.O :
* . REPORTS FIRST QUARTER 2019 RESULTS
* Q1 LOSS PER SHARE $2.71
* Q1 REVENUE $300,000
* Q1 REVENUE ESTIMATE $101,000 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX75wMHq
Further company coverage: PLXP.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on PLx Pharma Winddown
See all newsAustralia's Pilbara Minerals jumps on Pilgangoora lithium resource upgrade
Brief: Plx Pharma Winddown Terminated Employment Of Natasha Giordano, President And CEO, And Rita O'connor, CFO
Brief: PLx Pharma Inc. Enters Into A Stalking Horse Asset Purchase Agreement To Sell Vazalore And Substantially All Of Its Assets
U.S. STOCKS ON THE MOVE-HeartCore, Freight Technologies, MongoDB
Brief: Plx Pharma Inc. Receives Nasdaq Delisting Notice